Report Detail
Global Hypertension Drugs Market Professional Survey Report 2019
- RnM3784993 |
- 26 September, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Pharma & Healthcare
The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years.
In 2015, the Americas was the largest market for hypertension drugs as it accounted for more than 44% of the market share. The US is the major revenue contributor in the region. The market share is declining due to the patent expiries of drugs such as Micardis, Avapro, and Diovan. However, comorbid conditions among the older population like congenital heart disease and increasing focus on combination therapies will prevent the decline in the market. Moreover, the launch of new disease-modifying therapies is expected to bolster the growth prospects of the market during the forecast period.
The global Hypertension Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hypertension Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertension Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hypertension Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hypertension Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Segment by Application
Hospitals
Clinics
Others
Table of Contents
Executive Summary
1 Industry Overview of Hypertension Drugs
- 1.1 Definition of Hypertension Drugs
- 1.2 Hypertension Drugs Segment by Type
- 1.2.1 Global Hypertension Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Calcium Channel Blockers
- 1.2.3 Diuretics
- 1.2.4 Beta Blockers Vasodilators
- 1.2.5 Angiotensin Converting Enzyme Inhibitors
- 1.2.6 Alpha Blockers
- 1.2.7 Angiotensin Receptor Blockers
- 1.2.8 Renin Inhibitors
- 1.3 Hypertension Drugs Segment by Applications
- 1.3.1 Global Hypertension Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Global Hypertension Drugs Overall Market
- 1.4.1 Global Hypertension Drugs Revenue (2014-2025)
- 1.4.2 Global Hypertension Drugs Production (2014-2025)
- 1.4.3 North America Hypertension Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Hypertension Drugs Status and Prospect (2014-2025)
- 1.4.5 China Hypertension Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Hypertension Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Hypertension Drugs Status and Prospect (2014-2025)
- 1.4.8 India Hypertension Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Hypertension Drugs
- 2.3 Manufacturing Process Analysis of Hypertension Drugs
- 2.4 Industry Chain Structure of Hypertension Drugs
3 Development and Manufacturing Plants Analysis of Hypertension Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Hypertension Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Hypertension Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Hypertension Drugs Production and Capacity Analysis
- 4.2 Hypertension Drugs Revenue Analysis
- 4.3 Hypertension Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Hypertension Drugs Regional Market Analysis
- 5.1 Hypertension Drugs Production by Regions
- 5.1.1 Global Hypertension Drugs Production by Regions
- 5.1.2 Global Hypertension Drugs Revenue by Regions
- 5.2 Hypertension Drugs Consumption by Regions
- 5.3 North America Hypertension Drugs Market Analysis
- 5.3.1 North America Hypertension Drugs Production
- 5.3.2 North America Hypertension Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Hypertension Drugs Import and Export
- 5.4 Europe Hypertension Drugs Market Analysis
- 5.4.1 Europe Hypertension Drugs Production
- 5.4.2 Europe Hypertension Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Hypertension Drugs Import and Export
- 5.5 China Hypertension Drugs Market Analysis
- 5.5.1 China Hypertension Drugs Production
- 5.5.2 China Hypertension Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Hypertension Drugs Import and Export
- 5.6 Japan Hypertension Drugs Market Analysis
- 5.6.1 Japan Hypertension Drugs Production
- 5.6.2 Japan Hypertension Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Hypertension Drugs Import and Export
- 5.7 Southeast Asia Hypertension Drugs Market Analysis
- 5.7.1 Southeast Asia Hypertension Drugs Production
- 5.7.2 Southeast Asia Hypertension Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Hypertension Drugs Import and Export
- 5.8 India Hypertension Drugs Market Analysis
- 5.8.1 India Hypertension Drugs Production
- 5.8.2 India Hypertension Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Hypertension Drugs Import and Export
6 Hypertension Drugs Segment Market Analysis (by Type)
- 6.1 Global Hypertension Drugs Production by Type
- 6.2 Global Hypertension Drugs Revenue by Type
- 6.3 Hypertension Drugs Price by Type
7 Hypertension Drugs Segment Market Analysis (by Application)
- 7.1 Global Hypertension Drugs Consumption by Application
- 7.2 Global Hypertension Drugs Consumption Market Share by Application (2014-2019)
8 Hypertension Drugs Major Manufacturers Analysis
- 8.1 Novartis
- 8.1.1 Novartis Hypertension Drugs Production Sites and Area Served
- 8.1.2 Novartis Product Introduction, Application and Specification
- 8.1.3 Novartis Hypertension Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Daiichi Sankyo
- 8.2.1 Daiichi Sankyo Hypertension Drugs Production Sites and Area Served
- 8.2.2 Daiichi Sankyo Product Introduction, Application and Specification
- 8.2.3 Daiichi Sankyo Hypertension Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Actelion Pharmaceuticals
- 8.3.1 Actelion Pharmaceuticals Hypertension Drugs Production Sites and Area Served
- 8.3.2 Actelion Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 Actelion Pharmaceuticals Hypertension Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Boehringer Ingelheim
- 8.4.1 Boehringer Ingelheim Hypertension Drugs Production Sites and Area Served
- 8.4.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.4.3 Boehringer Ingelheim Hypertension Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Pfizer
- 8.5.1 Pfizer Hypertension Drugs Production Sites and Area Served
- 8.5.2 Pfizer Product Introduction, Application and Specification
- 8.5.3 Pfizer Hypertension Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
9 Development Trend of Analysis of Hypertension Drugs Market
- 9.1 Global Hypertension Drugs Market Trend Analysis
- 9.1.1 Global Hypertension Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Hypertension Drugs Regional Market Trend
- 9.2.1 North America Hypertension Drugs Forecast 2019-2025
- 9.2.2 Europe Hypertension Drugs Forecast 2019-2025
- 9.2.3 China Hypertension Drugs Forecast 2019-2025
- 9.2.4 Japan Hypertension Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Hypertension Drugs Forecast 2019-2025
- 9.2.6 India Hypertension Drugs Forecast 2019-2025
- 9.3 Hypertension Drugs Market Trend (Product Type)
- 9.4 Hypertension Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Hypertension Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Hypertension Drugs. Industry analysis & Market Report on Hypertension Drugs is a syndicated market report, published as Global Hypertension Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Hypertension Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
